David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
51
DELISTED
Citrix Systems Inc
CTXS
| $252M | 0.33% |
2,524,764
+888,665
| +54% | +$92.1M |
|
|
RHT
52
DELISTED
Red Hat Inc
RHT
| $251M | 0.32% |
1,371,972
+559,609
| +69% | +$100M |
|
53
Biogen
BIIB
$32B
| $248M | 0.32% |
1,048,621
+651,468
| +164% | +$205M |
|
54
Etsy
ETSY
$7.44B
| $246M | 0.32% |
3,654,611
+652,828
| +22% | +$39M |
|
|
TWTR
55
DELISTED
Twitter, Inc.
TWTR
| $244M | 0.31% |
7,409,210
-5,350,384
| -42% | -$170M |
|
56
EQT Corp
EQT
$33.6B
| $243M | 0.31% |
11,699,618
+229,402
| +2% | +$4.49M |
|
57
SLB Ltd
SLB
$79.9B
| $242M | 0.31% |
5,554,961
-4,598,871
| -45% | -$199M |
|
58
PUT
Meta Platforms (Facebook)
META
$1.4T
| $240M | 0.31% |
1,439,000
-927,200
| -39% | -$147M |
|
59
AT&T
T
$173B
| $239M | 0.31% |
10,082,359
-2,769,280
| -22% | -$63.7M |
|
60
GoDaddy
GDDY
$12.3B
| $231M | 0.3% |
3,066,372
-567,708
| -16% | -$39.9M |
|
61
Broadcom
AVGO
$1.75T
| $220M | 0.28% |
7,327,920
+5,636,460
| +333% | +$153M |
|
62
CALL
Alibaba
BABA
$286B
| $220M | 0.28% |
1,206,400
+549,600
| +84% | +$92.4M |
|
|
63
PUT
Booking.com
BKNG
$158B
| $218M | 0.28% |
3,122,500
-1,857,500
| -37% | -$133M |
|
|
EXAS
64
DELISTED
Exact Sciences
EXAS
| $216M | 0.28% |
2,496,750
+693,159
| +38% | +$59M |
|
65
Mondelez International
MDLZ
$82.3B
| $213M | 0.28% |
4,271,631
-3,899,538
| -48% | -$179M |
|
66
PUT
Apple
AAPL
$4.51T
| $211M | 0.27% |
4,442,000
+712,000
| +19% | +$30.2M |
|
67
Walmart Inc
WMT
$825B
| $211M | 0.27% |
6,483,312
-680,169
| -9% | -$22.1M |
|
68
PUT
Chipotle Mexican Grill
CMG
$46.7B
| $209M | 0.27% |
14,715,000
-6,470,000
| -31% | -$75.1M |
|
69
S&P Global
SPGI
$127B
| $208M | 0.27% |
986,703
-1,254,387
| -56% | -$243M |
|
70
IBM
IBM
$222B
| $208M | 0.27% |
1,539,465
-329,472
| -18% | -$42M |
|
|
SPR
71
DELISTED
Spirit AeroSystems
SPR
| $205M | 0.27% |
2,244,846
-81,927
| -4% | -$7.23M |
|
72
Hartford Financial Services
HIG
$36.9B
| $203M | 0.26% |
4,083,075
+17,007
| +0.4% | +$808K |
|
73
CALL
Netflix
NFLX
$331B
| $203M | 0.26% |
5,691,000
-2,355,000
| -29% | -$81.6M |
|
74
Royal Caribbean
RCL
$78.1B
| $199M | 0.26% |
1,736,481
+225,511
| +15% | +$25.6M |
|
|
75
PUT
Netflix
NFLX
$331B
| $199M | 0.26% |
5,578,000
-8,835,000
| -61% | -$306M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.